The EC has granted approval for presentation of GSK's Menveo vaccine (MenACWY) for invasive meningococcal disease (IMD).

The US Food and Drug Administration (FDA) has accepted a submission from GSK to review a new indication of Nucala ...

【葛兰素史克的液体脑膜炎疫苗获欧盟批准】葛兰素史克(GSK)的液体脑膜炎疫苗Menveo已获得欧盟委员会的批准，可在欧盟销售。这家英国制药公司周三表示，这种全液体疫苗有助于简化针对侵袭性脑膜炎球菌病(IMD)的疫苗接种流程，因为它为医疗健康提供者提供了一种无需在使用前进行复溶的选择。

The European Commission (EC) has approved a single-vial, fully liquid presentation of Menveo (meningococcal Group A, C, W-135 ...

Muna Therapeutics has entered a research alliance with GSK to expedite Alzheimer's disease treatments by discovering and ...

GSK’s fully liquid presentation of its meningococcal vaccine Menveo has been approved by the European Commission (EC) to ...

London: GSK plc has announced that the European Commission (EC) has approved a single-vial, fully liquid presentation of ...

The European Commission (EC) has granted approval for a single-vial, fully liquid presentation of GSK's Menveo vaccine (MenACWY), designed to protect against invasive meningococcal disease (IMD ...

GSK plc GSK announced that the European Commission (EC) has approved a single-vial, fully liquid presentation of its meningococcal vaccine, Menveo (MenACWY) for active immunization in children ...

GSK PLC on Wednesday said its meningitis vaccine, Menveo, has received approval from the European Commission in a new ... Subscribe now to see this Premium News article from Alliance News ...